Nitric oxide-induced p 53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p 53 ( tumor suppressor gene / mutagenesis / carcinogenesis )
KATHLEEN FORRESTER,STEFAN AMBS,SHAwN E. LUPOLD,RACHEL B. KAPUST,ELISA A. SPILLARE,WENDY C. WEINBERGt,EMANUELA FELLEY-BOSCOt,XIN W. WANG,DAVID A. GELLER,EDITH TZENG,TIMOTHY R. BILLIAR,CURTIS C. HARRIS
2005-01-01
Abstract:The tumor suppressor gene product p53 plays an important role in the cellular response to DNA damage from exogenous chemical and physical mutagens. Therefore, we hypothesized that p53 performs a similar role in response to putative endogenous mutagens, such as nitric oxide (NO). We report here that exposure of human cells to NO generated from an NO donor or from overexpression of inducible nitric oxide synthase (NOS2) results in p53 protein accumulation. In addition, expression of wild-type (WT) p53 in a variety of human tumor cell lines, as well as murine fibroblasts, results in down-regulation of NOS2 expression through inhibition of the NOS2 promoter. These data are consistent with the hypothesis of a negative feedback loop in which endogenous NO-induced DNA damage results in WT p53 accumulation and provides a novel mechanism by which p53 safeguards against DNA damage through p53-mediated transrepression of NOS2 gene expression, thus reducing the potential for NO-induced DNA damage. Nitric oxide (NO) is an important bioregulatory agent involved in a variety of biological processes including the immune response, cytotoxicity, neurotransmission, and vasodilation (1). NO is synthesized in vivo from L-arginine by isoforms of nitric oxide synthase (NOS) (2). The activities of the constitutive forms neuronal NOS (NOS1) and endothelial NOS (NOS3) are dependent on elevated concentrations of calcium (3). The inducible NOS isoform (NOS2) is active at resting concentrations of calcium in the cell (3). NOS2 is synthesized in a variety of cell types from multiple mammalian species and can produce consistent, high concentrations of NO upon induction with cytokines and/or bacterial lipopolysaccharide (LPS) (3). Biochemical reactions involving NO may also lead to DNA damage (4-6). High concentrations ofNO have been shown to cause deamination of deoxynucleotides and bases within intact DNA in vitro and are mutagenic in vivo (4, 7). Exposure of human cells to NO under aerobic conditions results in DNA strand breakage and nitrosative deamination of DNA bases (5). Therefore, NO can cause DNA damage as well as mutation in human cells. NO may also play a role in cytokine-induced (8) and activated macrophage-mediated (9) apoptosis of tumor cells. p53 plays an important role in the cellular response to DNA damage (10). DNA damage caused by exposure to ionizing radiation, UV, or some exogenous chemical mutagens that result in DNA strand breakage can trigger an accumulation of p53 (11, 12). p53 can activate transcription of growth regulatory genes such as p21WAF1/Cipl (13), GADD45 (14), and The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 2442 cyclin G (15), resulting in G1 growth arrest (16), presumably to allow for repair of damaged DNA. In addition, p53 can induce programmed cell death through the process of apoptosis (17, 18) to remove cells unable to repair damaged DNA. Since p53 plays an important role in the cellular response to DNA damage from exogenous chemical and physical mutagens (10), we hypothesized that p53 performs a similar role in response to putative endogenous mutagens such as NO and that DNA damage resulting from overproduction of NO induces wild-type (WT) p53 accumulation and subsequent down-regulation of NO synthesis through p53-mediated repression of NOS2 gene expression. MATERIALS AND METHODS Cell Lines and Plasmids. Primary normal human fibroblasts (NHFs) were obtained from the Coriell Cell Repository and grown in Eagle's minimal essential medium supplemented with 10% fetal bovine serum (FBS). THLE-5b cells, a simian virus 40 T-antigen immortalized normal human liver epithelial cell line grown in LCM medium (19), were infected with the retroviral vector DFG-iNOS containing the human NOS2 gene or with Bag-lacZ, containing the ,B-galactosidase gene as a vector control (20), and were selected on G418 (50 Ag/ml) to generate clonal cell lines. DLD-1, a human colon carcinoma cell line grown in A50 medium (Biofluids, Rockville, MD) supplemented with 10% FBS contains a mutant p53 (codon 241, C -> T). AKN-1, a spontaneously immortalized human liver cell line (21) grown in LCM medium contains a functionally inactive p53 (data not shown). Calu 6, a human lung adenocarcinoma cell line grown in HUT medium supplemented with 10% FBS, lacks endogenous p53 expression. Murine fibroblasts were isolated from dermis of 1to 4-day-old p53-deficient mice (GenPharm, Mountain View, CA) to identify the p53 status after genotyping (22, 23) and were grown in Dulbecco's modified Eagle's medium supplemented with 10% FBS. The p53 expression vectors contain a human (24) or murine (23) WT (pC53-WT) or mutant p53 under the control of the cytomegalovirus (CMV) promoter. pNOS2(1.3)Luc and pNOS2(7.0)Luc reporter constructs start at +33 and extend the indicated length of the human NOS2 5' flanking region (25) (21) liked to the luciferase gene in the pXP2 vector (26). Abbreviations: NOS2, nitric oxide synthase 2; LPS, lipopolysaccharide; WT, wild type; NHF, normal human fibroblast; CMV, cytomegalovirus; L-NMA, N-methyl-L-arginine; rh, recombinant human; IFN-y, interferon y; TNF-a, tumor necrosis factor a; IL-1X3, interleukin 1,3; RLU, relative light unit(s); S-NO-GS, S-nitrosoglutathione. ITo whom reprint requests should be addressed at: Laboratory of Human Carcinogenesis, National Cancer Institute, Building 37, Room 2C05, 37 Convent Drive, MSC 4255, Bethesda, MD 208924255. Proc. Natl. Acad. Sci. USA 93 (1996) 2443 The murine NOS2 reporter construct was obtained from C. J. Lowenstein (Johns Hopkins University, Baltimore) and contains a 1.7-kb fragment of the murine NOS2 regulatory region linked to the luciferase gene in the pGL2 vector (Promega) (27). Immunocytochemical Analysis. NHFs were treated with 1 mM S-nitrosoglutathione (S-NO-GS) (Calbiochem) or a mixture of 0.5 mM oxidized glutathione and 1 mM NaNO2. As a control, NHFs were treated with 20 ,uM cisplatin for 24 hr. THLE-5b cells were cultured in the presence or absence of 2 mM N-methyl-L-arginine (L-NMA; Calbiochem) for 48 hr. Cells were fixed with 2% paraformaldehyde (in PBS) and postfixed with methanol, immunolabeled with a 1:200 dilution of the anti-p53 polyclonal CM-1 antibody (Signet Laboratories, Dedham, MA), and incubated with a 1:300 dilution of a fluorescein isothiocyate or Texas Red-coupled secondary antibody (Vector Laboratories). Transient Transfection Assays and Cytokine Treatment. For NOS2 protein synthesis and activity determination, confluent DLD-1 cells were treated with lipofectin (GIBCO/ BRL) with 1 ,ug of human pC53-WT or pCMVneo vector control and 4 hr later cells were treated with a mixture of recombinant human (rh) interferon Ry (IFN-,y) (100 units/ml) (Boehringer Mannheim, Indianapolis, IN), rh interleukin 1/3 (IL-1/3) and rh tumor necrosis factor a (TNF-a) (10 ng/ml) (R&D Systems) and cultured with or without 2 mM L-NMA. After 48 hr, supernatant was analyzed for nitrate and nitrite production and cell lysates were prepared. For luciferase assays, cells at "80% confluency were treated with lipofectin with 1-3.5 jig of the pNOS2-Luc reporter and 1-10 jig of human or murine WT p53 expression vectors or the pCMVneo control vector. Following transfection, human cells were treated with IFN-,y (100 units/ml), IL-1j3 (1.2 ng/ml), and TNF-a for 8 hr (2 ng/ml), and cell extracts were prepared. Murine fibroblasts were treated with IFN--y (80 units/ml), IL-1f0 (1 ng/ml), and TNF-a (2 ng/ml) for 8 hr and cell extracts